L I Huschtscha
Overview
Explore the profile of L I Huschtscha including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
712
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hilton H, Santucci N, Silvestri A, Kantimm S, Huschtscha L, Graham J, et al.
Breast Cancer Res Treat
. 2014 Jan;
143(3):423-33.
PMID: 24395108
The epithelium of the human breast is made up of a branching ductal-lobular system, which is lined by a single layer of luminal cells surrounded by a contractile basal cell...
2.
Hilton H, Graham J, Kantimm S, Santucci N, Cloosterman D, Huschtscha L, et al.
Mol Cell Endocrinol
. 2012 May;
361(1-2):191-201.
PMID: 22580007
Progesterone is critical in normal breast development and its synthetic derivatives are emerging as major drivers of breast cancer risk. The recent demonstration that progesterone regulates the stem cell compartment...
3.
Huschtscha L, Neumann A, Noble J, Reddel R
Exp Cell Res
. 2001 Apr;
265(1):125-34.
PMID: 11281650
Under standard culture conditions, normal human mammary epithelial cells (HMECs) divide a limited number of times before proliferation ceases in a growth-arrested state referred to as selection. Cells that have...
4.
Yeager T, Neumann A, Englezou A, Huschtscha L, Noble J, Reddel R
Cancer Res
. 1999 Sep;
59(17):4175-9.
PMID: 10485449
Telomerase-negative immortalized human cells maintain their telomeres by a mechanism known as alternative lengthening of telomeres (ALT). We report here that ALT cells contain a novel promyelocytic leukemia (PML) body...
5.
Huschtscha L, Reddel R
Carcinogenesis
. 1999 Jun;
20(6):921-6.
PMID: 10357768
Normal somatic cells have a limited proliferative capacity in vitro: after a finite number of cell divisions they eventually enter a non-proliferative state referred to as senescence. Senescence is thought...
6.
Huschtscha L, Noble J, Neumann A, Moy E, Barry P, Melki J, et al.
Cancer Res
. 1998 Aug;
58(16):3508-12.
PMID: 9721850
Inactivation of p16INK4 tumor suppressor gene function is frequently observed in breast cancer. We examined p16INK4 expression in human mammary epithelial cell (HMEC) cultures established from four normal donors. Normal...
7.
Rutter A, Mackinnon W, Huschtscha L, Mountford C
Exp Gerontol
. 1996 Nov;
31(6):669-86.
PMID: 9415096
Proton magnetic resonance spectroscopy (1H MRS) has been used to monitor changes occurring during aging and transformation in human lung fibroblasts. Aging was studied in MRC-5 cells from nonsenescent (early...
8.
Huschtscha L, Bartier W, Ross C, Tattersall M
Br J Cancer
. 1996 Jan;
73(1):54-60.
PMID: 8554984
The characteristics of cell death were investigated after exposure of CCRF-CEM.f2 cells to five drugs over a broad concentration range; these were the glucocorticoid dexamethasone (DXM), the mitotic inhibitor vincristine...
9.
Huschtscha L, Jeitner T, Andersson C, Bartier W, Tattersall M
Exp Cell Res
. 1994 May;
212(1):161-5.
PMID: 8174637
Glucocorticoids kill human leukemic cells, CCRF-CEM.f2, by apoptosis. Cell death is preceded by DNA fragmentation into nucleosomal subunits which can be evaluated by DNA gel electrophoresis or by determining the...
10.
Hague A, Manning A, Hanlon K, Huschtscha L, Hart D, Paraskeva C
Int J Cancer
. 1993 Sep;
55(3):498-505.
PMID: 8397167
The purpose of this study was to determine whether cultured colonic adenoma and carcinoma cells undergo apoptosis (programmed cell death) in vitro and whether specific growth and dietary factors, thought...